(a)
(b)
(c)
(d)
Figure 1: Effect of YSSXG on blood parameters of patients with α-thalassemia and β-thalassemia disease at pre- and posttreatment (, resp.). , , compared with pretreatment. (a) The changes of Hb concentration. (b) The changes of RBC counts. (c) The changes of Ret level. (d) The changes of HbF level of patients with β-thalassemia disease.